The discovery that mutations in BRAF resulting in constitutive kinase activation are common occurrences in solid tumours (Davies et al, 2002) led a number of groups to analyse thyroid cancers for similar mutations in BRAF. Here, BRAF is linked to thyroid gland carcinoma.